ISSN (Print) - 0012-9976 | ISSN (Online) - 2349-8846

A+| A| A-

SOUTH AFRICA-Minority Apprehensions

that the drug control authorities and the ICMR have seen it fit to allow a controversial drug into the market when it is neither necessary nor essential. And significantly, the material presented by Upjohn at the medical conference earlier this week does not appear to remove the doubts expressed by the US public enquiry of 1984. The drug will reportedly be sold on the market on prescription and the company has agreed to undertake postmarketing surveillance. Since neither the ICMR nor the drug control authorities arc equipped to participate in this surveillance, it is unlikely that a company with a long record of unethical practices will conduct an ethical and honest appraisal of the drug on its own.

Dear Reader,

To continue reading, become a subscriber.

Explore our attractive subscription offers.

Click here

Back to Top